Clinical trial
The Use of Bacteriophage Phi X174 to Assess the Immune Competence of…
NCT00001540 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00001540 |
|---|---|
| Title | The Use of Bacteriophage Phi X174 to Assess the Immune Competence of HIV-Infected Patients In Vivo |
| Official title | The Use of Bacteriophage Phi X174 to Assess the Immune Competence of HIV-Infected Patients In Vivo |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV Infections |
| Enrollment | 52 |
| Start date | Apr 1, 1996 |
| Completion | Mar 1, 2000 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: